Alcohol Use Disorder Treatment Market Share

  • Report ID: 3804
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Alcohol Use Disorder Treatment Market Regional Analysis:

North America Market Insights

The North America alcohol use disorder treatment market is anticipated to register a significant share of 46% by 2035, amplifying its healthcare operations. The region benefits from a robust healthcare infrastructure and the ever-increasing demand for effective treatment measures for AUD. For instance, in December 2024, Adial Pharmaceuticals, Inc., notified that it had been granted a key U.S. patent number 12150931 expanding genotype coverage for its lead drug AD04 targeting alcohol and drug dependence. Hence, such activities strengthen their intellectual property portfolio, inspiring the global players by enabling targeted therapies based on genetic profiles.

The U.S. alcohol use disorder treatment market is witnessing significant growth driven by the ongoing efforts in research activities. Moreover, the country hosts substantial support groups, digital health initiatives, and new policies that aid in alcohol use disorder management. In November 2021, Pear Therapeutics declared that it secured a Breakthrough Device Designation from the U.S. FDA, which is a digital therapeutic that aids in the treatment of alcohol use disorder, reSET-A, with a positive outlook, widening the market scope. Furthermore, supportive regulations have enhanced innovations, leading to a surge in the number of clinical trials and approvals of advanced, groundbreaking therapies in the alcohol use disorder treatment market.

The Canada market is growing steadily, supported by the government, a strong drug research environment, and collaborative industry partnerships. With a strong focus on regulatory reforms, dependence treatment programs, and other health initiatives, the country is anticipated to witness considerable growth during the forecast period. In June 2021, Health Canada initiated three support projects with nearly USD 2 million in Alberta and Newfoundland and Labrador, aiming to address alcohol-associated disorders, including AUD. Under this project, Boyle Street Service Society, St. John’s Women’s Centre, and the McMan Youth, Family and Community Services Association will be receiving funding, thereby uplifting market growth.

APAC Market Insights

The Asia Pacific region houses a large and assorted population, including a substantial number of addicted individuals who require effective treatment measures through various strategies. This grants appreciable market prospects for healthcare facilities providing treatment in the region, further expanding market growth. The region is also widening access to rehabilitation programs, medications, and digital health innovation to support alcohol use disorder treatment in the region. Thus, these factors significantly boost the market in the region, demonstrating lucrative growth opportunities during the forecast timeline.

India’s alcohol use disorder treatment market is particularly supported by a robust pharmaceutical industry, regulatory reforms, and financial support for biopharmaceuticals. Moreover, the exceptional support from the government spurred the rehabilitation of alcohol use, aiming to position India as a regional hub for dependence therapy. In January 2024, as published by the MoSJE under the National Action Plan for Drug Demand Reduction, supports prevention, treatment, and rehabilitation of substance abuse through up to 95% financial aid to NGOs and states such as Jammu and Kashmir and the North East regions. This support from the government uplifts the market growth in the region. 

The China alcohol use disorder treatment market is driven by a large patient base with a huge addiction to alcohol. The government’s commitment to supporting pharmaceutical innovation, combined with favorable regulatory adjustments for faster approvals, has fostered a favorable business environment. As per the NLM report in February 2020, alcohol dependence in the country led to 381,200 deaths in a year, with a lowered overall life expectancy by 0.43 years. It further stated that the incidence among 18 to 69-year-olds was 35.7%, in men 55.6% in women. Hence, due to the rising burden, the country’s market is anticipated to witness lucrative growth during the forecast period.

Alcohol Use Disorder Treatment Market Share

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of alcohol use disorder treatment is estimated at USD 1.43 billion.

The global alcohol use disorder treatment market size was more than USD 1.36 billion in 2025 and is anticipated to grow at a CAGR of over 6.1%, reaching USD 2.46 billion revenue by 2035.

North America alcohol use disorder treatment market will hold around 46% share by 2035, driven by the robust healthcare infrastructure and growing demand for AUD treatments.

Key players in the market include Teva Pharmaceutical Industries Ltd., BioCorRx, Inc, Adial Pharmaceuticals, ADDEX Therapeutics, Kinnov Therapeutics, Opiant Pharmaceuticals.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos